IL1B and opsoclonus-myoclonus syndrome: At 3 and 6 h post-infection, OMS-treated BMDMs and PMs had significantly higher mRNA levels of Tnf, Il1b, and Il12p40 compared to untreated controls (Figure 4(a) and Supplementary Figure S2).